MDT
Medtronic plc
Healthcare • NYSE • CIK 0001613103
Loading...
Market Cap
$110.46B
P/E (TTM)
21.1x
Rev Growth (TTM)
+9.8%
Net Margin (TTM)
13.9%
FCF Yield (TTM)
5.6%
FCF Margin (TTM)
16.3%
Figures as of July 31, 2026
Filings
Primary-source SEC disclosures, read end-to-end — every figure traceable to its filing.
8-KSep 20262026-09-17source
10-Q2027 Q12026-09-03source
8-KEarnings2026-09-01source
10-K2026 FY2026-06-18source
8-KEarnings2026-06-03source
What your agent reads
Investor Relations
Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.
IR decks — not catalogued
Company-published, not SEC-audited
Earnings
Q1
about 1 month ago
8-K releaseRevenue
$9.76B
+13.7%
Net Income
$1.47B
+41.4%
EPS
$1.14
+40.7%
Earnings call — not catalogued
Most recent quarterly earnings snapshot
Cash Flow Health
Free Cash Flow8/8 positive
TTM$6.1B
Q1 '27
$1.3B-38%
Q4 '26
$2.1B-9%
FCF Margin
TTM16.3%
Q1 '2713.2%-38%
Sector: 0.7%Top 25%
OCF Margin
21.4%
OCF/NI1.54x
CapEx Coverage
4.2x
FCF Yield5.6%
FCF Growth (3Y)+11%
Cash Conversion Cycle
160 days
DSO: 62+DIO: 170−DPO: 72
Cash flow trends & capital efficiency
Capital Allocation
Total Shareholder YieldTTM
TTM4.4%
Div Yield3.3%
+Buyback (TTM)1.1%
Dividend & Payout Metrics
Dividend Yield (TTM)3.3%
FCF Payout Ratio59.5%
Free Cash Flow (TTM)$6.1B
Stock Repurchases (TTM)$1.2B
Capital Return / FCF78.8%
Shares Outstanding (YoY)-0.1%↓ Buyback
Est. Dividends Paid (TTM)$3.6B
Shows how management rewards shareholders
Valuation Metrics
Price-to-EarningsTTM
21.1x
Volatile
8Q: 22.6x-276%
Valuation Lenses
Earnings
21.1x
vs – sector
Cash Flow
21.2x
EV/FCF vs –
Growth-Adj
1.7xPEG
Fair for growth
Quality-Adj
3.0P/E per %ROIC
ROIC: 7.0%
Shareholder Returns
Dividend
3.3%
Buyback
1.1%
Total Yield
4.4%
Market Cap$110.46B
EV$129.79B
Multi-angle valuation analysis with sector context
Margins & Efficiency
ROIC 73th pctile
Profitability Cascade
Gross
65.0%
Operating
18.1%
Top 25% in sector
Net
13.9%
Margins Unknown
Return on Invested CapitalTTM
7.0%
Stable
+0.0% YoY8Q: 6.8%+0.2%
P25MedianP75
73th pctl (med: -7.4%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
14.4%
8Q: 14.3%
Asset Turnover
0.41x
8Q: 0.39x
Leverage (1+D/E)
1.56x
D/E: 0.56x
DuPont: 9.2% ≈ 7.0% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
5.18x
8Q:5.17x
+3.0%
Invested Cap Turn
0.51x
8Q:0.49x
+5.3%
CapEx Intensity
2.6%
8Q:2.6%
CapEx/Depreciation
0.65x
FCF vs Net Margin Gap+2.4 pts
Depreciation Rate Trend
⚠ Declining -2.1%
Margin trends, ROIC, and capital efficiency
Balance Sheet & Solvency
ND/EBITDA 2.8x
Net Debt / EBITDA
2.8xNet Debt: $19.33B
Interest Coverage
9.4x
+Strong interest coverage: 9.4x
Leverage Metrics
Debt-to-Equity
0.56x
Balance sheet risk & solvency analysis
Related Research
2 related posts